RxDoctor Payments Data

Nina Hensley

Family · Manchester, KYNPI 1699029207

Payments from drug & device makers

$3,624in general payments, 2019–2025

Across 231 payments — averaging $15.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$889
  • Novo Nordisk$670
  • GSK$352
  • AstraZeneca$272
  • Lilly USA, LLC$215
  • Merck$192
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$3,624100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,624 in reported general payments places this provider in the 85th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin150$91,207
EliquisApixaban116$69,357
LinzessLinaclotide106$58,573
MounjaroTirzepatide47$48,751
OzempicSemaglutide40$43,435
Trelegy ElliptaFluticasone/Umeclidin/Vilanter48$31,148
Albuterol Sulfate HfaAlbuterol Sulfate593$17,396
TradjentaLinagliptin24$15,478
Breztri AerosphereBudesonide/Glycopyr/Formoterol22$13,701
Combivent RespimatIpratropium/Albuterol Sulfate27$12,987
Humalog Mix 75-25 KwikpenInsulin Lispro Protamin/Lispro40$9,729
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen805$8,913
JanuviaSitagliptin Phosphate16$8,912
BrilintaTicagrelor16$8,736
FarxigaDapagliflozin Propanediol11$8,611

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat$28$119,672201 claims
PfizerEliquis, Dilantin$85$71,134128 claims
AbbVieLinzess$889$58,573106 claims
Lilly USA, LLCMounjaro, Humalog$215$50,64064 claims
Novo NordiskOzempic, Novolog$670$46,77558 claims
AstraZenecaBreztri Aerosphere, Brilinta, Farxiga, Symbicort$272$35,44369 claims
GSKTrelegy Ellipta$352$31,14848 claims
MerckJanuvia$192$8,91216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,374 family providers in Kentucky.

Other family in Manchester

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →